Optimal donor selection for transplant to reduce GVHD risk and augment graft-versus-malignancy efficacy
Authors:
- 30 April 2026
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 100, 102783
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute
- National Cancer Institute (U24CA076518)
- Health Resources and Services Administration (75R60222C00011)
- National Marrow Donor Program
- Medical College of Wisconsin
- National Institute of Allergy and Infectious Diseases
- U.S. Public Health Service (U24CA076518)
This publication has 38 references indexed in Scilit:
- Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 TrialTransplantation and Cellular Therapy, 2025
- Search Summary Score: A Global Measure to Predict Matched Unrelated Stem Cell Donor AvailabilityTransplantation and Cellular Therapy, 2025
- Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy – A Report from the CIBMTRTransplantation and Cellular Therapy, 2025
- Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMTThe Lancet Haematology, 2024
- Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemiaAmerican Journal of Hematology, 2023
- Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantationInternational Journal of Hematology, 2023
- Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters MostTransplantation and Cellular Therapy, 2018
- On Modeling Human Leukocyte Antigen–Identical Sibling Match Probability for Allogeneic Hematopoietic Cell Transplantation: Estimating the Need for an Unrelated Donor SourceTransplantation and Cellular Therapy, 2016
- Patient HLA-DP–Specific CD4+ T Cells from HLA-DPB1–Mismatched Donor Lymphocyte Infusion Can Induce Graft-versus-Leukemia Reactivity in the Presence or Absence of Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2013
- Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective studyThe Lancet Oncology, 2012